PL2563771T3 - Związki inhibitora metaloenzymu - Google Patents
Związki inhibitora metaloenzymuInfo
- Publication number
- PL2563771T3 PL2563771T3 PL11772772T PL11772772T PL2563771T3 PL 2563771 T3 PL2563771 T3 PL 2563771T3 PL 11772772 T PL11772772 T PL 11772772T PL 11772772 T PL11772772 T PL 11772772T PL 2563771 T3 PL2563771 T3 PL 2563771T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibitor compounds
- metalloenzyme inhibitor
- metalloenzyme
- compounds
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32766310P | 2010-04-24 | 2010-04-24 | |
| PCT/US2011/033597 WO2011133875A2 (en) | 2010-04-24 | 2011-04-22 | Metalloenzyme inhibitor compounds |
| EP11772772.7A EP2563771B1 (en) | 2010-04-24 | 2011-04-22 | Metalloenzyme inhibitor compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2563771T3 true PL2563771T3 (pl) | 2016-06-30 |
Family
ID=44834829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11772772T PL2563771T3 (pl) | 2010-04-24 | 2011-04-22 | Związki inhibitora metaloenzymu |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8236962B2 (pl) |
| EP (1) | EP2563771B1 (pl) |
| JP (2) | JP5266430B2 (pl) |
| KR (1) | KR101379370B1 (pl) |
| CN (1) | CN103097374B (pl) |
| AU (1) | AU2011242562B2 (pl) |
| BR (1) | BR112012027308B1 (pl) |
| CA (2) | CA2792950C (pl) |
| CY (1) | CY1117678T1 (pl) |
| DK (1) | DK2563771T3 (pl) |
| EA (1) | EA024341B1 (pl) |
| ES (1) | ES2563319T3 (pl) |
| HR (1) | HRP20160172T1 (pl) |
| HU (1) | HUE026474T2 (pl) |
| PL (1) | PL2563771T3 (pl) |
| PT (1) | PT2563771E (pl) |
| RS (1) | RS55010B1 (pl) |
| SI (1) | SI2563771T1 (pl) |
| TW (1) | TWI578987B (pl) |
| WO (1) | WO2011133875A2 (pl) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2485592T3 (en) | 2009-10-07 | 2016-09-05 | Dow Agrosciences Llc | Synergistic fungicidal compounds for mushrooms fight in cereals |
| SI2563771T1 (sl) * | 2010-04-24 | 2016-05-31 | Viamet Pharmaceuticals, Inc. | Spojine inhibitorjev metaloencimov |
| KR101594660B1 (ko) | 2010-08-04 | 2016-02-16 | 펠피큐어 파마슈티걸즈 아이엔씨 | 전립선 암종의 치료를 위한 병용 요법 |
| KR20140040235A (ko) | 2011-06-19 | 2014-04-02 | 비아멧 파마슈티컬즈, 인코포레이티드 | 금속효소 억제제 화합물 |
| WO2012177635A1 (en) * | 2011-06-19 | 2012-12-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| JP2014523880A (ja) | 2011-06-23 | 2014-09-18 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 金属酵素化合物 |
| RS57248B1 (sr) * | 2011-12-11 | 2018-07-31 | Viamet Pharmaceuticals Nc Inc | Jedinjenja inhibitori metaloenzima |
| IN2014DN06792A (pl) * | 2012-01-20 | 2015-05-22 | Viamet Pharmaceuticals Inc | |
| IN2014DN06812A (pl) * | 2012-01-20 | 2015-05-22 | Viamet Pharmaceuticals Inc | |
| TWI646088B (zh) * | 2012-03-16 | 2019-01-01 | 維愛美製藥公司 | 金屬酶抑制劑化合物 |
| TWI654180B (zh) | 2012-06-29 | 2019-03-21 | 美商艾佛艾姆希公司 | 殺真菌之雜環羧醯胺 |
| EP2894981B1 (en) * | 2012-09-12 | 2019-12-04 | Dow AgroSciences LLC | Metalloenzyme inhibitor compounds |
| LT2938191T (lt) | 2012-12-28 | 2018-05-10 | Dow Agrosciences Llc | Sinergistiniai fungicidiniai mišiniai, skirti grybelių kontrolei javuose |
| CA2894551A1 (en) | 2012-12-31 | 2014-07-03 | Dow Agrosciences Llc | Macrocyclic picolinamides as fungicides |
| BR112015018547A2 (pt) * | 2013-02-04 | 2017-07-18 | Syngenta Participations Ag | microbiocidas |
| AU2014241816B9 (en) | 2013-03-14 | 2019-02-14 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
| EP3008051A4 (en) | 2013-06-12 | 2017-03-01 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| WO2015100181A1 (en) | 2013-12-26 | 2015-07-02 | Dow Agrosciences Llc | Macrocyclic picolinamide compounds with fungicidal activity |
| EP3099170A4 (en) | 2013-12-26 | 2017-06-21 | Dow AgroSciences LLC | Use of macrocyclic picolinamides as fungicides |
| AU2015231270B2 (en) * | 2014-03-19 | 2019-03-07 | Viamet Pharmaceuticals (NC), Inc. | Antifungal compound process |
| JP2017509646A (ja) * | 2014-03-19 | 2017-04-06 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 抗真菌化合物の調製方法 |
| JP2017507991A (ja) * | 2014-03-19 | 2017-03-23 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 抗真菌化合物の調製方法 |
| CA2942968C (en) * | 2014-03-19 | 2022-03-15 | William J. Hoekstra | Antifungal compound process |
| US9914726B2 (en) | 2014-03-19 | 2018-03-13 | Vps-3, Inc. | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and processes for their preparation |
| US10196375B2 (en) | 2014-03-19 | 2019-02-05 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| JP6572234B2 (ja) * | 2014-03-19 | 2019-09-04 | ヴィアメット ファーマスーティカルズ（エヌシー），インコーポレイテッド | 抗真菌化合物の調製方法 |
| WO2015143154A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| CN109678791B (zh) | 2014-03-19 | 2022-07-01 | 美国陶氏益农公司 | 1-(2,4-二氟苯)-2,2-二氟-2-(5-取代吡啶-2-基)乙酮及制备方法 |
| US10017494B2 (en) | 2014-03-19 | 2018-07-10 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| CA2945674A1 (en) * | 2014-04-15 | 2015-10-22 | Dow Agrosciences Llc | Metalloenzyme inhibitor compounds as fungicides |
| US20150322051A1 (en) | 2014-05-06 | 2015-11-12 | Dow Agrosciences Llc | Macrocyclic picolinamides as fungicides |
| JP2017525753A (ja) | 2014-06-06 | 2017-09-07 | フレクサス・バイオサイエンシーズ・インコーポレイテッドＦｌｅｘｕｓ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． | 免疫調節剤 |
| CN106470982A (zh) | 2014-07-08 | 2017-03-01 | 美国陶氏益农公司 | 作为杀真菌剂的大环吡啶酰胺 |
| WO2016007531A1 (en) | 2014-07-08 | 2016-01-14 | Dow Agrosciences Llc | Macrocyclic picolinamides as fungicides |
| WO2016040896A1 (en) | 2014-09-12 | 2016-03-17 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| AR102537A1 (es) | 2014-11-05 | 2017-03-08 | Flexus Biosciences Inc | Agentes inmunomoduladores |
| UY36390A (es) | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
| EA201790806A1 (ru) | 2014-11-05 | 2017-11-30 | Флексус Байосайенсиз, Инк. | Иммунорегулирующие средства |
| AU2015374379B2 (en) | 2014-12-30 | 2018-10-04 | Dow Agrosciences Llc | Picolinamides as fungicides |
| UA121763C2 (uk) | 2014-12-30 | 2020-07-27 | Дау Аґросаєнсиз Елелсі | Фунгіцидні сполуки |
| EP3808181A1 (en) | 2014-12-30 | 2021-04-21 | Dow AgroSciences LLC | Use of picolinamide compounds as fungicides |
| MX2017008418A (es) | 2014-12-30 | 2017-09-28 | Dow Agrosciences Llc | Picolinamidas con actividad fungicida. |
| RU2704867C2 (ru) | 2014-12-30 | 2019-10-31 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Применение соединений пиколинамида с фунгицидным действием |
| CN107205398B (zh) | 2014-12-30 | 2020-08-21 | 美国陶氏益农公司 | 具有杀真菌活性的吡啶酰胺化合物 |
| CN107428724B (zh) | 2015-03-19 | 2021-07-02 | 迈科维亚医药公司 | 抗真菌化合物及制备方法 |
| CA2986041C (en) | 2015-05-18 | 2021-06-29 | Viamet Pharmaceuticals, Inc. | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioxo-4,5-dihydro-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile compounds as antifungal agents |
| BR112018005194B1 (pt) * | 2015-09-18 | 2022-11-08 | Vps-3, Inc | Processo para preparar um composto antifúngico |
| MX376201B (es) * | 2015-12-30 | 2025-03-07 | Nqp 1598 Ltd | Compuestos inhibidores de metaloenzima. |
| US10173982B2 (en) | 2016-08-30 | 2019-01-08 | Dow Agrosciences Llc | Picolinamides as fungicides |
| WO2018045010A1 (en) | 2016-08-30 | 2018-03-08 | Dow Agrosciences Llc | Pyrido-1,3-oxazine-2,4-dione compounds with fungicidal activity |
| US10231452B2 (en) | 2016-08-30 | 2019-03-19 | Dow Agrosciences Llc | Thiopicolinamide compounds with fungicidal activity |
| US10111432B2 (en) | 2016-08-30 | 2018-10-30 | Dow Agrosciences Llc | Picolinamide N-oxide compounds with fungicidal activity |
| WO2018080933A1 (en) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
| WO2018119440A1 (en) | 2016-12-22 | 2018-06-28 | Calithera Biosciences, Inc. | Compositions and methods for inhibiting arginase activity |
| CA3055292A1 (en) * | 2016-12-29 | 2018-07-05 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
| BR102018000183B1 (pt) | 2017-01-05 | 2023-04-25 | Dow Agrosciences Llc | Picolinamidas, composição para controle de um patógeno fúngico, e método para controle e prevenção de um ataque por fungos em uma planta |
| TW201842851A (zh) | 2017-05-02 | 2018-12-16 | 美商陶氏農業科學公司 | 用於穀類中的真菌防治之協同性混合物 |
| TWI774761B (zh) | 2017-05-02 | 2022-08-21 | 美商科迪華農業科技有限責任公司 | 用於穀物中的真菌防治之協同性混合物 |
| CN110996665B (zh) | 2017-05-02 | 2021-10-26 | 陶氏益农公司 | 无环吡啶酰胺化合物作为针对草坪草上的真菌病害的杀真菌剂的用途 |
| WO2019092086A1 (en) | 2017-11-13 | 2019-05-16 | Bayer Aktiengesellschaft | Tetrazolylpropyl derivatives and their use as fungicides |
| BR102019004480B1 (pt) | 2018-03-08 | 2023-03-28 | Dow Agrosciences Llc | Picolinamidas como fungicidas |
| EP3866597A4 (en) | 2018-10-15 | 2022-06-29 | Corteva Agriscience LLC | Methods for sythesis of oxypicolinamides |
| US12281076B2 (en) | 2019-10-18 | 2025-04-22 | Corteva Agriscience Llc | Process for synthesis of picolinamides |
| WO2021143811A1 (zh) * | 2020-01-17 | 2021-07-22 | 上海森辉医药有限公司 | 四氮唑类化合物的可药用盐及其结晶形式、制备方法和用途 |
| WO2021188404A1 (en) | 2020-03-19 | 2021-09-23 | Assia Chemical Industries Ltd | Solid state forms of oteseconazole and process for preparation thereof |
| CN117069693A (zh) * | 2022-05-16 | 2023-11-17 | 上海济煜医药科技有限公司 | 一类含胺基结构化合物的制备方法及作为抗菌剂的应用 |
| WO2024067784A1 (zh) * | 2022-09-30 | 2024-04-04 | 上海济煜医药科技有限公司 | 双环类化合物的无定形、结晶固体及其制备方法 |
| WO2025109158A1 (en) | 2023-11-23 | 2025-05-30 | Basf Se | Process for the chemical recycling of plastic waste containing polyethylene or polypropylene |
| WO2026006142A1 (en) * | 2024-06-24 | 2026-01-02 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Azole compounds useful as inhibitors of voltage-dependent anion channel oligomerization |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8304282D0 (en) * | 1983-02-16 | 1983-03-23 | Pfizer Ltd | Antifungal agents |
| US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
| US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
| US4738851A (en) | 1985-09-27 | 1988-04-19 | University Of Iowa Research Foundation, Inc. | Controlled release ophthalmic gel formulation |
| US5084465A (en) * | 1986-06-23 | 1992-01-28 | Du Pont Merck Pharmaceutical Company | Antifungal carbinols |
| US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
| US4882150A (en) | 1988-06-03 | 1989-11-21 | Kaufman Herbert E | Drug delivery system |
| GB8819308D0 (en) * | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Triazole antifungal agents |
| US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
| US5521222A (en) | 1989-09-28 | 1996-05-28 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| CA2031376A1 (en) | 1989-12-04 | 1991-06-05 | Bahram Farhadieh | Single layer transdermal drug administration system |
| US5077033A (en) | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
| DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
| US5352456A (en) | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
| CA2123809A1 (en) | 1991-12-18 | 1993-06-24 | Debra L. Wilfong | Multilayered barrier structures |
| ATE132381T1 (de) | 1992-01-29 | 1996-01-15 | Voelkl Franz Ski | Ballspielschläger, insbesondere tennisschläger |
| JP3452213B2 (ja) * | 1994-07-05 | 2003-09-29 | エーザイ株式会社 | 抗真菌剤及びその製造方法 |
| IL114193A (en) | 1994-06-20 | 2000-02-29 | Teva Pharma | Ophthalmic pharmaceutical compositions based on sodium alginate |
| ES2094688B1 (es) | 1994-08-08 | 1997-08-01 | Cusi Lab | Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion. |
| GB9512961D0 (en) * | 1995-06-26 | 1995-08-30 | Pfizer Ltd | Antifungal agents |
| JPH1045750A (ja) * | 1995-09-20 | 1998-02-17 | Takeda Chem Ind Ltd | アゾール化合物、その製造方法及び用途 |
| IT1283911B1 (it) | 1996-02-05 | 1998-05-07 | Farmigea Spa | Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo |
| GB9605705D0 (en) * | 1996-03-19 | 1996-05-22 | Pfizer Ltd | Therapeutic agents |
| US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
| US6197934B1 (en) | 1998-05-22 | 2001-03-06 | Collagenesis, Inc. | Compound delivery using rapidly dissolving collagen film |
| JP2000344744A (ja) * | 1999-06-04 | 2000-12-12 | Ss Pharmaceut Co Ltd | アセトフェノン誘導体およびその製法 |
| JP2004359646A (ja) | 2003-06-09 | 2004-12-24 | Ss Pharmaceut Co Ltd | 抗真菌活性を有する新規アゾール誘導体 |
| SI2563771T1 (sl) * | 2010-04-24 | 2016-05-31 | Viamet Pharmaceuticals, Inc. | Spojine inhibitorjev metaloencimov |
-
2011
- 2011-04-22 SI SI201130741A patent/SI2563771T1/sl unknown
- 2011-04-22 DK DK11772772.7T patent/DK2563771T3/en active
- 2011-04-22 ES ES11772772.7T patent/ES2563319T3/es active Active
- 2011-04-22 CN CN201180030668.5A patent/CN103097374B/zh active Active
- 2011-04-22 AU AU2011242562A patent/AU2011242562B2/en active Active
- 2011-04-22 JP JP2013506326A patent/JP5266430B2/ja active Active
- 2011-04-22 HU HUE11772772A patent/HUE026474T2/en unknown
- 2011-04-22 BR BR112012027308-6A patent/BR112012027308B1/pt active IP Right Grant
- 2011-04-22 RS RS20160236A patent/RS55010B1/sr unknown
- 2011-04-22 CA CA2792950A patent/CA2792950C/en active Active
- 2011-04-22 HR HRP20160172TT patent/HRP20160172T1/hr unknown
- 2011-04-22 WO PCT/US2011/033597 patent/WO2011133875A2/en not_active Ceased
- 2011-04-22 KR KR1020127030824A patent/KR101379370B1/ko active Active
- 2011-04-22 PL PL11772772T patent/PL2563771T3/pl unknown
- 2011-04-22 EP EP11772772.7A patent/EP2563771B1/en active Active
- 2011-04-22 PT PT117727727T patent/PT2563771E/pt unknown
- 2011-04-22 CA CA2837400A patent/CA2837400C/en active Active
- 2011-04-22 EA EA201291107A patent/EA024341B1/ru not_active IP Right Cessation
- 2011-04-25 TW TW100114248A patent/TWI578987B/zh active
- 2011-04-25 US US13/093,530 patent/US8236962B2/en active Active - Reinstated
-
2012
- 2012-07-30 US US13/561,586 patent/US8754227B2/en active Active
-
2013
- 2013-05-02 JP JP2013096967A patent/JP5944343B2/ja active Active
-
2016
- 2016-02-24 CY CY20161100153T patent/CY1117678T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2563771E (pt) | Compostos inibidores de metaloenzimas | |
| ZA201400232B (en) | Metalloenzyme inhibitor compounds | |
| EP2723731A4 (en) | COMPOUNDS INHIBITING METALLOENZYMES | |
| HUE037899T2 (hu) | Metalloenzim inhibitor vegyületek | |
| EP2804479A4 (en) | METALLOENZYME INHIBITOR COMPOUNDS | |
| GB201004311D0 (en) | New enzyme inhibitor compounds | |
| EP2894981A4 (en) | METALLO ENZYME INHIBITOR COMPOUNDS | |
| GB201008134D0 (en) | Compounds | |
| GB201015949D0 (en) | Compounds | |
| PL2804858T3 (pl) | Związki - inhibitory metaloenzymu | |
| EP2519508A4 (en) | METALLO ENZYME INHIBITOR COMPOUNDS | |
| GB201007347D0 (en) | Compounds | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| EP2649050A4 (en) | LINKS | |
| EP2632903A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
| EP2651905A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
| GB201008209D0 (en) | Compounds | |
| GB201001688D0 (en) | Compounds | |
| EP2751117A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
| GB201001796D0 (en) | Compounds | |
| GB201002216D0 (en) | Compounds | |
| GB201015537D0 (en) | Compounds | |
| GB201008210D0 (en) | Compounds | |
| PL2558462T3 (pl) | Pirydylo-winylo-pirazolo-chinoliny jako inhibitory PAR1 | |
| TWI561515B (en) | Metalloenzyme inhibitor compounds |